Auckland City Harbour News - - YOUR LOCAL NEWS “A FRENCH CONNECTION” -

Re­searchers at the Univer­sity of Auck­land are seek­ing smok­ers to par­tic­i­pate in a world-lead­ing clin­i­cal trial of a new smok­ing ces­sa­tion drug called Champix. El­i­gi­ble par­tic­i­pants must be 18 years or older, a daily-smoker who wishes to quit, have sta­ble Chronic Ob­struc­tive Pul­monary Dis­ease(COPD), and not have used Champix in the last 12 months. As­so­ci­ate pro­fes­sor Natalie Walker said quit­ting smok­ing and stay­ing smoke­free was the only in­ter­ven­tion that would halt the rapid de­cline in lung func­tion seen with COPD. Champix is cur­rently the most ef­fec­tive medicine in pre­vent­ing re­lapse in re­cent ex-smok­ers avail­able in New Zealand. To reg­is­ter in­ter­est in par­tic­i­pat­ing call 0800 367 644, email space­trial@auck­land.ac.nz, or con­tact via Face­book @SPACE­trial.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.